Health
Key biomarker for inflammation and COVID-19 risk – Medical Xpress
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage…
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
In a new paper in International Journal of Infectious Diseases, medical experts in Italy and Australia examined levels of a chemical called serum amyloid A (SAA), a protein synthesized in the liver which can spike up to 1,000-fold within the first 24-48 hours of an infection.
…
-
Noosa News22 hours agoDrivers call out bad manners and most hated acts on Queensland roads
-
Business23 hours agoHow to build a $250,000 passive income portfolio starting from zero
-
Noosa News24 hours agoBrisbane Lions looking for rookie Levi Ashcroft to step up against Gold Coast in absence of Lachie Neale
-
Noosa News22 hours agoCoochin Fields developer asked to explain shortfalls in tourist park proposal